CHRISTINA LAKE CANNABIS - Asset Resilience Ratio
CHRISTINA LAKE CANNABIS (CLB) has an Asset Resilience Ratio of 0.19% as of November 2025. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See CLB free cash flow debt coverage to measure the company's free cash flow as a share of total liabilities.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio Trend (2021–2024)
This chart shows how CHRISTINA LAKE CANNABIS's Asset Resilience Ratio has changed over time. See CLB net asset quality score to measure how much of total assets are equity-financed.
Liquid Assets Composition Over Time
This chart breaks down CHRISTINA LAKE CANNABIS's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For market capitalisation and broader financial context, see CHRISTINA LAKE CANNABIS stock valuation.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | €0.00 | 0% |
| Short-term Investments | €52.31K | 0.19% |
| Total Liquid Assets | €52.31K | 0.19% |
Asset Resilience Insights
- Limited Liquidity: CHRISTINA LAKE CANNABIS maintains only 0.19% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
CHRISTINA LAKE CANNABIS Industry Peers by Asset Resilience Ratio
Compare CHRISTINA LAKE CANNABIS's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Haleon plc
NYSE:HLN |
Drug Manufacturers - Specialty & Generic | 4.06% |
|
Viatris Inc
NASDAQ:VTRS |
Drug Manufacturers - Specialty & Generic | 0.29% |
|
Neuland Laboratories Limited
NSE:NEULANDLAB |
Drug Manufacturers - Specialty & Generic | 6.06% |
|
Ningbo Menovo Pharm Co Ltd
SHG:603538 |
Drug Manufacturers - Specialty & Generic | 3.28% |
|
Shenzhen Chipscreen Biosciences Co
SHG:688321 |
Drug Manufacturers - Specialty & Generic | 5.10% |
|
Tianjin Ringpu Bio Tech
SHE:300119 |
Drug Manufacturers - Specialty & Generic | 14.27% |
|
China Animal Husbandry Industry Co Ltd
SHG:600195 |
Drug Manufacturers - Specialty & Generic | 3.81% |
|
Shandong Shanda Wit Science and Technology Co Ltd
SHE:000915 |
Drug Manufacturers - Specialty & Generic | 25.22% |
Annual Asset Resilience Ratio for CHRISTINA LAKE CANNABIS (2021–2024)
The table below shows the annual Asset Resilience Ratio data for CHRISTINA LAKE CANNABIS.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2024-11-30 | 0.21% | €50.00K ≈ $58.46K |
€23.37 Million ≈ $27.32 Million |
-- |
| 2023-11-30 | 0.00% | €0.00 ≈ $0.00 |
€15.96 Million ≈ $18.66 Million |
-- |
| 2022-11-30 | 0.15% | €28.75K ≈ $33.61K |
€18.79 Million ≈ $21.97 Million |
+0.00pp |
| 2021-11-30 | 0.15% | €28.75K ≈ $33.61K |
€19.04 Million ≈ $22.26 Million |
-- |
About CHRISTINA LAKE CANNABIS
Christina Lake Cannabis Corp., a license cannabis producer, engages in the research and development, cultivation, processing, production, and sale of cannabis in Canada. It offers distilled and winterized oils; kief products; and additional extracted products. The company was formerly known as Cervantes Capital Corp. and changed its name to Christina Lake Cannabis Corp. in December 2018. Christin… Read more